Noble News

News

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

As healthcare continues its shift toward home-based care and self-administration, ensuring patients can use complex drug delivery devices correctly has never been more important. To support this evolving landscape, Noble, an Aptar Pharma company, has been awarded a new U.S. patent for an artificial intelligence-enabled method that uses sound recognition technology to help determine whether a drug delivery or diagnostic device has been operated correctly.

Learn more

News

Starting with Curiosity: The Journey of Noble’s First Scholar

On June 2, Noble welcomed its first-ever Noble Scholar, launching a new chapter in the company’s commitment to developing future talent.

Learn more

News

Noble Hosts Ceremony Celebrating Support for Redemption Home

At Noble, creating a positive impact extends beyond the healthcare solutions we provide. It also means supporting the communities where we live and work. Recently, Noble welcomed employees, community leaders, and representatives from Redemption Home to its Orlando headquarters for a special ceremony celebrating the organization’s mission of providing mentorship, stability, and opportunity for young men across Central Florida.

Learn more

News

Noble’s Sean Glynn Discusses First-Dose Confidence and Adherence in Pharmaceutical Executive Podcast

Noble’s Director of Patient Engagement Services, Sean Glynn, recently appeared on a Pharmaceutical Executive podcast to discuss the role of first-dose experiences in patient adherence and persistence for self-injectable therapies.

Learn more

News

From Touchpoints to Moments: Noble’s Perspective Coming Out of the PanAgora Pharma CX Summit 

At the PanAgora Pharma CX Summit, one theme stood out across nearly every conversation: customer experience is no longer a supporting function in pharma. It is a core growth lever that directly influences treatment decisions, adherence, trust, and long-term value.

Learn more

News

Aptar and Enable Injections Advance Patient‑Centered Digital Support

As combination products continue to advance, the industry is moving beyond reliable drug delivery alone—and toward solutions that support patients throughout the entire treatment journey.

Learn more